This year’s annual meeting of the American Society of Clinical Oncology (ASCO) conference has proven to be both enjoyable and thought provoking with plenty of new data to peruse and learn from.

In this latest round-up we explore and discuss some of the key oral and poster sessions from yesterday, which was a frenetic day from beginning to end, including thought leader interviews in between sessions.

The last morning of the final day of ASCO or AACR is always a bit eerie for the committed diehards who remain to the bitter end for the science in the all important tumour biology session:

To learn more from our latest ASCO highlights and get a heads up on our oncology insights, subscribers can log-in or you can click to gain access to BSB Premium Content.

This content is restricted to subscribers

Posted by